Lv3
246 积分 2025-11-04 加入
High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails
23小时前
已完结
Reprogramming human T cell function and specificity with non-viral genome targeting
9天前
已完结
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
9天前
已完结
Expanding access to CAR T cell therapies through local manufacturing
14天前
已完结
Single-day nonactivated IL-18-armed CAR T cells establish a durable, stemlike state with enhanced persistence
20天前
已完结
Rapid manufacturing of non-activated potent CAR T cells
20天前
已完结
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma
1个月前
已完结
Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor–T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1)
2个月前
已完结
Genetically Stable and Scalable Nanoengineering of Human Primary T Cells via Cell Mechanoporation
2个月前
已完结
Vector copy number quality control testing for CAR T-cells: critical validation parameters
2个月前
已完结
皖公网安备34019202002308
